JSI Research & Training Institute, Inc. has partnered with the Sabin Vaccine Institute and Dalberg to create the COVID-19 Vaccine Equity Project. This collaboration will support low- and middle-income country immunization professionals in leading the equitable delivery of COVID-19 vaccines through their national immunization programs. It complements the approach outlined in the COVAX Facility, the vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A)—led by the World Health Organization (WHO); Gavi, the Vaccine Alliance (Gavi); and the Coalition for Epidemic Preparedness Innovations (CEPI).
The Skoll Foundation is generously supporting the creation of the COVID-19 Vaccine Equity Project through start-up funding of $1 million to begin assistance with four countries. Following a successful pilot, the partners hope to secure additional funding to scale the project to more than 40 countries starting in 2021.
We strive to build lasting relationships to produce better health outcomes for all.
